Etanercept ineffective for moderate-to-severe asthma - PulmCCM
Advertisement
Jun 062011
 

TNF-alpha can be elevated in severe asthmatics’ sputum and bronchial tissue. Could blocking it help? Holgate et al randomized 132 people with moderate or severe persistent asthma to receive 25 mg etanercept or placebo injections for 12 weeks. There was no difference in the primary endpoint (change in FEV1 at 12 weeks) nor in exacerbations, Asthma Control Questionnaire and quality of life scores, or methacholine concentration needed to provoke bronchoconstriction. (n=132) ERJ 2011;37:1352-1359.

Liked this post? Get a weekly email update (no spam, ever), and explore our library of clinical guidelines, practice updatesreview articles. and board review questions.

PulmCCM is an independent publication, not affiliated with or endorsed by any other organization, society or journal referenced on the website.

Leave a Comment